mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.009 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
AZD-2281 |
FIMM |
pan-cancer |
AAC |
0.44 |
0.01 |